What Anebulo Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| English Aron R. | Director | Dec 23 | Open-market buy · P | +10,101,010 | $0.99 | +$10M | 15,467,300 |
| English Aron R. | Director | Dec 18 | Gift · G | +300,000 | — | — | 5,366,290 |
| English Aron R. | Director | Dec 18 | Gift · G | −300,000 | — | — | 0 |
| English Aron R. | Director | Nov 13 | Grant / award · A | +300,000 | — | — | 300,000 |
| English Aron R. | Director | Sep 28 | Grant / award · A | +1,703,577 | $2.81 | +$4.79M | 5,066,290 |
| English Aron R. | Director | Dec 17 | Open-market buy · P | +400 | $6.59 | +$2.63K | 3,362,713 |
| English Aron R. | Director | Dec 14 | Open-market buy · P | +412 | $5.90 | +$2.43K | 3,362,313 |
| English Aron R. | Director | Dec 03 | Open-market buy · P | +4,500 | $5.93 | +$26.7K | 3,361,901 |
| English Aron R. | Director | Dec 02 | Open-market buy · P | +13,836 | $5.30 | +$73.3K | 3,357,401 |
| English Aron R. | Director | May 06 | Grant / award · A | +714,286 | $7.00 | +$5M | 3,343,601 |
| English Aron R. | Director | May 06 | Grant / award · A | +714,250 | $7.00 | +$5M | 3,343,565 |
Loading...
